Back
Open Access

Long-term efficacy of mavacamten on health status in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: results from long-term extension of the EXPLORER-CN trial

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (3)
Topic: Hypertrophic Cardiomyopathy
Speaker: Mr M. Hurst (Pontyclun, GB)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Michael Hurst

Pontyclun (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

7 more presentations in this session

Mavacamten eligibility in an Irish hypertrophic cardiomyopathy cohort

Speaker: Mr P. Kopp (Stony Brook, US)

Access
Abstract
Like
Thumbnail

Usefulness of implantable loop recorders in patients with hypertrophic cardiomyopathy

Speaker: Doctor M. Figueiredo (Barreiro, PT)

Access
Abstract
Like
Thumbnail

Medical education significantly improves the recognition of red flags of transthyretin cardiac amyloidosis

Speaker: Doctor C. Rohani-Montez (London, GB)

Access
Abstract
Like
Thumbnail

Reduction of >100 mmHg left ventricular outflow tract gradients in obstructive hypertrophic cardiomyopathy during mavacamten treatment already after one week of treatment

Speaker: Doctor R. Sepp (Szeged, HU)

Access
Abstract
Like
Thumbnail

Temporal changes in echocardiographic parameters of diastolic dysfunction in obstructive hypertrophic cardiomyopathy during mavacamten treatment

Speaker: Doctor H. Takacs (Szeged, HU)

Access
Abstract
Like
Thumbnail

Access the full session

ePosters in myocardial disease - hypertrophic cardiomyopathy (3)

Speakers: Mr M. Hurst, Mr P. Kopp, Doctor M. Figueiredo, Doctor C. Rohani-Montez, Doctor R. Sepp...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources